SENNA-PLUS
- Product NDC
- 80136-555
- 11-digit product format
- 801360555
- Labeler code
- 80136
- Product ID
- 80136-555_45263661-3ac1-6283-e063-6394a90ac1ec
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Sennosides and Docusate Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Heartland Pharma Co.
- Application
- 505G(a)(3)
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2022-12-01
- Marketing end
- 2026-06-30
- Substance
- DOCUSATE SODIUM; SENNOSIDES
- Active strength
- 50; 8.6 mg/1; mg/1
- NDC exclude flag
- No
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- SENNA-PLUS
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DOCUSATE SODIUM | 50 mg/1 |
| SENNOSIDES | 8.6 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | F05Q2T2JA0, 3FYP5M0IJX |
| Rxcui | 998740 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 80136-555-01 | SENNA-PLUS | 100 in 1 BOTTLE | TABLET | 100 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 80136-555 | SENNA-PLUS (SENNOSIDES AND DOCUSATE SODIUM) TABLET [NORTHEAST PHARMA] | 3 | Current NDC, 1 package rows | 20231201_fd653118-18c7-463e-e053-6294a90a2c7e.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 80136-555-01 | 80136055501 | 100 TABLET in 1 BOTTLE (80136-555-01) | 100 tablet | 2022-12-01 | 2026-06-30 | No | No | Historical |